Less intensive drug schedule as effective as standard treatment for blood cancer
Monday, August 23, 2010 - 17:49
in Health & Medicine
A less intensive bortezomib-based regimen (given once instead of twice per week) followed by maintenance therapy, is as effective as the standard treatment for elderly patients with multiple myeloma, but with fewer serious side effects, and will be a valuable treatment option in these patients, according to an Article published Online First in The Lancet Oncology.